{"a": [["Metformin hydrochloride", "1999"], ["Metformin", "1996"], ["Epidemiology of adverse drug reactions to phenformin and metformin", "1978"], ["Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus", "2007"], ["Lactic acidosis rates in type 2 diabetes", "1998"], ["Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy", "2002"], ["Metformin and the sulphonylureas: The comparative risk", "1985"], ["Worldwide experience of metformin as an effective glucose\u2010lowering agent: A meta\u2010analysis", "1995"], ["Pharmacologic therapy for type 2 diabetes mellitus", "1999"], ["Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: a systematic review", "2007"], ["Statistical methods for rates and proportions", "1981"], ["Biguanide\u2010assoicated lactic acidosis: case report and review of the literature", "1992"], ["Balancing risk and benefit with oral hypoglycemic drugs", "2009"], ["Contra\u2010indications to metformin therapy are largely disregarded", "1999"], ["Assessing the quality of reports of randomized clinical trials: Is blinding necessary?", "1996"], ["Lactate homerostasis and lactic acidosis", "1980"], ["Lactic acidosis in metformin therapy: searching for a link with metformin in reports of 'metformin\u2010associated lactic acidosis'.", "2001"], ["Lactic acidosis in biguanide\u2010treated diabetics: a review of 330 cases", "1978"], ["Lacic acidosis in patients with diabetes treated with metformin", "1998"], ["Lactic acidosis", "1970"], ["Metformin reduces insulin requirements in type 1 (insulin\u2010dependent) diabetes", "1983"], ["Metformin: Effects of cardiovascular risk factors in patients with non\u2010insulin\u2010dependent diabetes mellitus", "1998"], ["Metformin monotherapy for type 2 diabetes mellitus", "2005"], ["Clinical pharmacokinetics of metformin", "1996"], ["Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials", "1995"], ["Re\u2010evaluation of a biguanide, metformin: mechanism of action and tolerability", "1994"], ["Matformin and lactic acidosis: guilt by association?", "1998"], ["Incidence of lactic acidosis in metformin users", "1999"], ["[Treatment of Diabetes mellitus with N.N. Dimethyl Guanil Guanidine (LA 6023, glucophage)]", "1959"], ["Meta\u2010analysis of observational studies in epidemiology. A proposal for reporting", "2000"], ["Contraindications to metformin therapy in patients with NIDDM", "1997"], ["Metformin\u2010associated lactic acidosis in Sweden 1977\u20101991", "1993"]], "ex": [["Biguanide related lactic acidosis: incidence and risk factors", "1992"], ["Glycaemic control and adverse events in patients with type 2 diabetes treated with metformin + sulphonylurea: a meta\u2010analysis", "2008"], ["Effect of pioglitazone in combination with insulin therapy on glycaemic control, insulin dose requirement and lipid profile in patients with type 2 diabetes previously poorly controlled with combination therapy", "2007"], ["[Tolbutamide\u2010dimethyl\u2010biguanide association in the treatment of diabetes mellitus]", "1965"], ["Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia a nested case\u2010control analysis", "2008"], ["Determination of plasma Metformin by a new cation\u2010exchange HPLC technique", "1999"], ["[Blood lactate and biguanide therapy: comparison between phenformin, metformin and buformin in 408 senile diabetics]", "1978"], ["Effectiveness of Glibenclamide on myocardial ischemic ventricular arrhythmias in non\u2010insulin\u2010dependent Diabetes mellitus", "1991"], ["Relationship between HbA1c and hypoglycaemia in patients with type 2 diabetes treated with different insulin regimens in combination with metformin", "2009"], ["Explaining the decline in early mortality in men and women with type 2 diabetes: a population\u2010based cohort study", "2008"], ["Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients", "1995"], ["Saytime Glibenclamide and bedtime NPH insulin compared to intensive insulin treatment in secondary Sulphonylurea failure: a 1\u2010year follow\u2010up", "1995"], ["Effects of pioglitazone in combination with metformin or a sulfonylurea compared to a fixed\u2010dose combination of metformin and glibenclamide in patients with type 2 diabetes", "2007"], ["The effect of pioglitazone as add\u2010on therapy to metformin or sulphonylurea compared to a fixed\u2010dose combination of metformin and glibenclamide on diabetic dyslipidaemia", "2008"], ["Metformin treatment in NIDDM patients with mild renal impairment", "1996"], ["Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes", "2005"], ["Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide", "2008"], ["Metformin and insulin: is there a role for combination therapy?", "1997"], ["[Study of lactic acid levels on an empty stomach in diabetic patients treated with N\u2010N\u2010dimethylbiguanide]", "1964"], ["[Results of the treatment of Diabetes mellitus in the adult with the association of Metformin and sulfamides (concerning 197 cases)]", "1966"], ["[Results of the treatment of Diabetes mellitus in the adult with metformin (concerning 202 cases0]", "1966"], ["Pioglitazone metabolic effect in metformin\u2010intolerant obese patients treated with sibutramine", "2009"], ["Metformin prolongs the posptrandial fall in plasma ghrelin concentrations in type 2 diabetes", "2007"], ["Improved clinical outcomes associated with metformin in patients with diabetes and heart failure", "2005"], ["Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus", "2005"], ["Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin", "2006"], ["Intensification of oxidative stress and inflammation in type 2 diabetes despite antihyperglycemic treatment", "2008"], ["Impairment of the antioxidant properties of serum albumin in patients with diabetes: Protective effects of metformin", "2008"], ["Effects of metformin on the pathways of glucose utilization after oral glucose in non\u2010insulin\u2010dependent diabetes mellitus patients", "1997"], ["Efficacy and safety of exenatide administered before the two largest daily meals of Latin American patients with type 2 diabetes", "2008"], ["Effect of metformin on insulin\u2010stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDM", "1994"], ["Choice of treatment affects plasma levels of insulin\u2010like growth factor\u2010binding protein\u20101 in noninsulin\u2010dependent Diabetes mellitus", "1995"], ["Metformin reduces post\u2010prandial insulin needs in Type 1 (Insulin\u2010dependent) diabetic patients: Assessment by the artificial pancreas", "1982"], ["Metformin improved insulin resistance in type I, insulin\u2010dependent, diabetic patients", "1985"], ["Study of the effect of metformin on platelet aggregation in insulin\u2010dependent diabetics", "1989"], ["Effects of metformin on plasma glucose, insulin, FFA, glucagon, growth hormone and cortisol responses to oral glucose in subjects with chemical diabetes", "1979"], ["High and typical 18F\u2010FDG bowel uptake in patients treated with metformin", "2008"], ["Treatment of non\u2010insulin\u2010dependent diabetes mellitus with metformin", "1997"], ["Can family physicians help patients initiate basal insulin therapy successfully?: Randomized trial of patient\u2010titrated insulin glargine compared with standard oral therapy: Lessons for family practice from the Canadian INSIGHT trial", "2008"], ["Study of the pharmacokinetic interaction of vildagliptin and metformin in patients with type 2 diabetes", "2009"], ["Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase\u20104 inhibitor sitagliptin when co\u2010administered in patients with type 2 diabetes", "2006"], ["Efficacy and safety of the dipeptidyl peptidase\u20104 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin", "2007"], ["Impact of prandial plus basal vs basal insulin on glycemic variability in type 2 diabetic patients", "2009"], ["Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open\u2010label trial", "2009"], ["Population exposure\u2010response modeling of metformin in patients with type 2 diabetes mellitus", "2008"], ["[The risk of lacticate acidosis: a comparison of the 3 biguanides in treatment of diabetics (authors' transl)]", "1978"], ["The effect of metformin on individual amino acid absorption", "1978"], ["[Glycemic equilibrium and weight evolution in diabetics taking metformin]", "1991"], ["[Long term treatment with biguanides in the natural evolution of non\u2010insulin\u2010dependent diabetes]", "1996"], ["The effect of metformin on adipose tissue metabolism and peripheral blood flow in subjects with NIDDM", "1996"], ["A comparative study of the effects of hypogycemic agents on serum electrolutes in the diabetic patients", "2007"], ["Efficacy of metformin in the treatment of NIDDM: Meta\u2010analysis", "1999"], ["Metformin and lactic acidosis in an Australian community setting: the Fremantle Diabetes Study", "2008"], ["Rosiglitazone improves insulin sensitivity with increased serum leptin levels in patients with type 2 diabetes mellitus", "2008"], ["Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study)", "2008"], ["Metformin\u2010associated lactic acidosis in diabetic patients with acute renal failure. A critical analysis of its pathogenesis and prognosis", "1994"], ["Role of metformin accumulation in metformin\u2010associated lactic acidosis", "1995"], ["[Efficacy and safety of the use of metformin in patients with chronic heart failure and type 2 diabetes mellitus. results of the study &quot;rational effective mulicomponent therapy in the battle against diabetes mellitus in patients with chronic heart failure&quot;]. [Russian]", "2008"], ["Energy expenditure in non\u2010insulin dependent diabetic subjects on metformin or sulphonylurea therapy", "1987"], ["Metformin compared with tolbutamide in the treatment of maturity\u2010onset diabetes mellitus", "1970"], ["Thiazolidinedione addition reduces the serum retinol\u2010binding protein 4 in type 2 diabetic patients treated with metformin and sulfonylurea", "2008"], ["Metformin increases blood flow and forearm glucose uptake in a group of non\u2010obese type 2 diabetes patients", "2006"], ["Thiazolidinediones, metformin and outcomes in older patients with diabetes and heart failure", "2005"], ["The impact of glucose lowering treatment on long\u2010term prognosis in patients with type 2 diabetes and myocardial infarction: A report from the DIGAMI 2 trial", "2008"], ["[Treatment of 81 cases of diabetes mellitus with N.N. dimethyl\u2010biguanide]", "1965"], ["[Treatment of diabetes mellitus with N.N. dimethy\u2010biguanide]", "1966"], ["Three\u2010year mortality in diabetic patients treated with different combinations of insulin secretagogues and metformin", "2006"], ["Comparison of different drugs as add\u2010on treatments to metformin in type 2 diabetes: A meta\u2010analysis", "2008"], ["Effect of combined secretagogue/biguanide treatment on mortality in type 2 diabetic patients with and without ischemic heart disease", "2008"], ["[Dimethyl\u2010biguanide in the treatment of diabetes mellitus]", "1965"], ["Normalization of fasting hyperglycaemia by exogenous glucagon\u2010like peptide 1 (17\u201036 amide) in Type 2 (non\u2010insulin\u2010dependent) diabetic patients", "1993"], ["Glucagon\u2010like peptide 1 and its potential in the treatment of non\u2010insulin\u2010dependent Diabetes mellitus", "1997"], ["Adding liraglutide to oral antidiabetic drug monotherapy: Efficacy and weight benefits", "2009"], ["Care of adults with type 2 diabetes mellitus. A review of the evidence [see comments]", "1998"], ["Long\u2010term efficacy of metformin therapy in nonobese individuals with type 2 diabetes", "2006"], ["[Influence of N.N. dimethyl biguandie on certain elements of lipid metabolism in diabetic patients]", "1966"], ["Determinants of plasminogin activatory inhibitor 1 activiry in treated NIDDM and its relation to a polymorphosm in the Plasminogen Activator Inhibitor 1 gene", "1995"], ["Therapeutic options for elderly diabetic subjects: Open label, randomized clinical trial of insulin glargine added to oral antidiabetic drugs versus increased dosage of oral antidiabetic drugs", "2008"], ["Acute antihyperglycemic mechanisms of Metformin in NIDDM: Evidence for suppression of lipid oxidation and hepatic glucose production", "1994"], ["[Effect of biguanide therapy on lactate metabolism during graded submaximal ergometric testing]", "1978"], ["Insulin receptor binding to monocytes, insulin secretion, and glucose tolerance following metformin treatment. Results of a double\u2010blind cross\u2010over study in type II diabetics", "1983"], ["[Treatment of diabetes mellitus with NN\u2010dimethyl\u2010diguanide. Experience of 177 cases]", "1961"], ["Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all\u2010 cause mortality?", "2008"], ["Circadian variation of glucose, insulin, and free fatty acids during long\u2010term use of oral hypoglycaemic agents in diabetes mellitus", "1968"], ["Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients", "1986"], ["Prevalence of risk determinants for metformin\u2010associated lactic acidosis and metformin utilization in the study of health in pomerania.[erratum appears in Horm Metab Res. 2008 Oct;40(10):735]", "2008"], ["Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin\u2010dependent diabetes mellitus", "1996"], ["Effect of metformin on bile salt circulation and intestinal motility in type 2 diabetes mellitus", "1998"], ["Metabolic effects of glucocorticoid and ethanol administration in phenformin\u2010 and metformin\u2010treated obese diabetics", "1979"], ["First 20 months' experience with use of metformin for type 2 diabetes in a large health maintenance organization", "1999"], ["2\u2010Year effects of pioglitazone add\u2010on to sulfonylurea or metformin on oral glucose tolerance in patients with Type 2 diabetes", "2008"], ["Retrospecitve review of metformin in inpatients and outpatients at the University of Michigan", "2006"], ["The effect of metformin on liver blood flow in vivo in normal subjects and patients with non insulin dependent diabetes", "1996"], ["Dose\u2010response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population\u2010based cohort study", "2006"], ["Sucrose taken during mixed meal has no additional hypergycemic action over isocaloric amounts of starch in well\u2010controlled diabetics", "1984"], ["Reversal of increased lymphocyte PC\u20101 activity in patients with type 2 diabetes treated with metformin", "1999"], ["[Clinical trial with DMBG (Melbin) in diabetes mellitus]", "1962"], ["The effect of intravenous Metformin on glucose metabolism during hyperglycemia in Type 2 Diabetes", "1992"], ["[Biguanides and sulfamides in small doses in the initial treatment of diabetes in obese patients]", "1963"], ["Clinical characteristics influencing the effectiveness of metformin on Japanese type 2 diabetes receiving sulfonylureas", "2007"], ["Metformin normalizes insulin binding to monocytes from obese nondiabetic subjects and obese type II diabetic patients", "1983"], ["Lessons from IK prospective diabetes study", "1995"], ["A comparative study of the glycemic control of various antidiabetic agents and the role of homocysteine in the therapy of type 2 diabetes mellitus", "2008"], ["Effect of oral antidiabetic agents on plasma amylin level in patients with non\u2010insulin\u2010dependent Diabetes mellitus (Type 2)", "1999"], ["Metformin plus roziglitazone versus metformin for type 2 diabetes: A systematic review", "2009"]], "in": [["Folate administration reduces circulating homocysteine levels in NIDDM patients on long\u2010term metformin treatment", "1998"], ["Results of a placebo\u2010controlled study of the metabolic effects of the addition of metformin to sulfonylurea\u2010treated patients. Evidence for a central role of adipose tissue", "1997"], ["Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin [see comments]", "1998"], ["Metformin\u2010induced lacicadidemia in patients with type 2 diabetes mellitus", "2000"], ["Vascular effects of glibenclamide, glimepiride, metformin and acarbose in Type 2 DM patients", "2000"], ["Effect of metformin therapy on plasma adiponectin and leptin levels in obese and insulin resistant postmenopausal females with type 2 diabetes", "2007"], ["Combination daytime chlorpropamide\u2010metformin/bedtime insulin in the treatment of secondary failures in non insulin dependent diabetes", "1992"], ["Improved meal\u2010related beta\u2010cell function and insulin sensitivity by the dipeptidyl peptidase\u2010IV inhibitor Vildagliptin in metformin\u2010treated patients with type 2 diabetes over 1 year", "2005"], ["[Dimethylbiguanide in the treatment of diabetes mellitus]", "1961"], ["The short\u2010term effect of a switch from glibenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus", "2000"], ["[Experience with biguanide treatment for diabetes mellitus]", "1962"], ["Effects of basal insulin analog and metformin on glycaemia control and weight as risk factors for endothelial dysfunction", "2008"], ["Effects of metformin in patients with poorly controlled, insulin\u2010treated type 2 diabetes mellitus. A randomized, double\u2010blind, placebo\u2010controlled trial", "1999"], ["[Treatment of diabetes with NN\u2010Dimethyl Biguanide]", "1960"], ["[N.N. dimethyl\u2010biguanide (DMGG) in the treatment of Diabetes meliitus]", "1961"], ["Rosiglitazone/Metformin fixed\u2010dose combination compared iwth uptitrated metformin alone in type 2 diabetes mellitus: a 24\u2010week multicenter randomized double\u2010blind parallel\u2010group study", "2005"], ["Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10mg+ metformin SR 500mg in diabetic dyslipidaemia in adult Indian patients", "2008"], ["Metabonomic variations in the drug\u2010treated type 2 diabetes mellitus patients and healthy volunteers", "2009"], ["Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c", "2000"], ["Effects of pioglitazone and metformin on NEFA\u2010induced insulin resistance in type 2 diabetes", "2008"], ["Increaesed intake of calcium reverses vitamin B12 malabsroption induced by metformin", "2000"], ["A comparison of acarbose versus metformin as an adjuvant therapy in sulfonylurea\u2010treated NIDDM patients", "1996"], ["Metformin reduces systemic methylglyoxal levels in type 2 diabetes", "1999"], ["Changes in liver tests during 1\u2010year treatment of patients with type 2 diabetes with pioglitazone, metformin or glicazinde", "2005"], ["Outcome of metformin\u2010facilitated reinitiation of oral diabetic therapy in insulin\u2010treated patients with non\u2010insulin\u2010dependent diabetes mellitus", "1997"], ["Homeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes", "2008"], ["Metformin plus low\u2010dose glimerperide significantly improves homeostasis model assessment for insulin resistance (HOMA\u2010IR) and beta\u2010cell function (HOMA\u2010beta\u2010cell) without hyperinsulinemia in patients with type 2 diabetes mellitus", "2007"], ["A randomized study of orlistat in combination with a weight management programme in obese patients with type 2 diabetes treated with metformin", "2004"], ["Long\u2010term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes", "2005"], ["[Results in the treatment of diabetes with glucophage retard]", "1975"], ["Efficacy of once\u2010 or twice\u2010daily extended release metformin compared with thrice\u2010daily immediate release metformin in type 2 diabetes mellitus", "2005"], ["Metformin combined with chlorpropamide in the treatment of Diabetes mellitus", "1964"], ["Influence of phenformin and metformin on exercise induced lactataemia in patients with diabetes mellitus", "1978"], ["Glyburide/Metformin combination product is safe and efficacious in patients with type 2 diabetes failing sulphonylurea therapy", "2002"], ["[Effectiveness of treatment with metformin in patients with type 2 diabetes mellitus poorly controlled with insulin treatment]", "2000"], ["Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment\u2010naive patients with type 2 diabetes mellitus", "2009"], ["Association of lactic acidosis with biguanide therapy [letter]", "1977"], ["Insulin, glibenclamide or metformin treatment for non insulin dependent diabetes: heterogenous responses of standard measures of insulin action and insulin secretion before and after differing hypoglycaemic therapy", "1992"], ["Effect of adding sitagliptin, a dipeptidyl peptidase\u20104 inhibitor, to metformin on 24\u2010h glycaemic control and beta\u2010cell function in patients with type 2 diabetes", "2007"], ["Metformin as secondary therapy in a defined population with Type 2 Diabetes", "1999"], ["Beta\u2010cell response to metformin\u2010gli benclamide combination tablets (Glucovance) in patients with type 2 diabetes", "2006"], ["A comparison of phenformin and metformin in the treatment of maturity onset diabetes", "1977"], ["Comparison between acarbose, metformin, and insulin treatment in type 2 diabetic patients with secondary failure to sulfonylurea treatment", "1995"], ["Effects of metformin on blood pressure and microalbuminuria in diabetes mellitus", "1988"], ["One year comparative trial of metformin and glipizide in type 2 diabetes mellitus", "1994"], ["[The treatment of Diabetes mellitus: Statistical results after a review of 1190 cases]", "1962"], ["Influence of metformin on arginine\u2010induced glucagon secretion in human diabetes", "1975"], ["Metformin reduces C\u2010reactive protein but not complement factor C3 in overweight patients with type 2 diabetes mellitus", "2005"], ["The hyperlactatemic effect of biguanides: a comparison between phenformin and metformin during a 6\u2010month treatment", "1989"], ["Effect of combination glipizide GITS/Metformin on fibrinolytic and metabolic parameters in poorly controlled type 2 diabetic subjects", "2002"], ["Comparison of effect of pioglitazone with metformin or sulfonylurea (monotherapy and combination therapy) on postload glycemia and composite insulin sensitivity index during an oral glucose tolerance test in patients with type 2 diabetes", "2005"], ["Fibrinolyitic effect of metformin in coronary\u2010artety disease", "1965"], ["Effects of early use of pioglitazone in combination with metformin in patients with newly diagnosed type 2 diabetes", "2007"], ["Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients", "1993"], ["Improved glycemic control by addition of glumepiride to metformin monotherapy in type 2 diabetic patients", "2001"], ["The efficacy of acarbose in the treatment of patients with non\u2010insulin\u2010dependent diabetes mellitus. A multicenter controlled clinical trial [see comments]", "1994"], ["The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes", "2001"], ["Plasma t\u2010PA and PAl\u20101 antigen concentrations in non\u2010insulin dependent diabetic patients: effects of treatment modality on fibrinolysis", "1992"], ["Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabtic subjects", "2002"], ["Safety and efficacy of repaglinide in combination with metformin and bedtime NPH insulin as an insulin treatment regimen in type 2 diabetes", "2008"], ["Combined Metformin\u2010Chlorpropamide therapy in 108 diabetic sulphonylurea\u2010failures", "1965"], ["Comparison of chlorpropamide and metformin treatment on weight and blood\u2010glucose response of uncontrolled obese diabetics", "1968"], ["Comparison of metformin and chlorpropamide in non\u2010obese, maturity\u2010onset diabetics uncontrolled by diet", "1977"], ["Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non\u2010insulin\u2010dependent) diabetic patients", "1989"], ["Monotherapy with metformin: does it improve hypoxia in type 2 diabetic patients?", "2001"], ["Comparative outcomes study of metformin intervention versus conventional approach", "2005"], ["Metabolic effects of metformin on glucose and lactate metabolism in noninsulin\u2010dependent diabetes mellitus", "1996"], ["[Comparison of two treatment models in type\u2010II diabetic patients with poor metabolic control: Preformed combination of glibenclamide 2,5 mg + metformin 400 mg or mono\u2010therapy with sulfonylurea at maximal doses? An evaluation at six months]", "1996"], ["Irreversibility of the defect in glycogen synthase activity in skeletal muscle from obese patients with NIDDM treated with diet and metformin", "1998"], ["Effect of metformin/glyburide tablets on HBA1c in first\u2010line treatment of Type 2 Diabetes", "2000"], ["A randomized controlled trial examining combinations of repaglinide, metformin and NPH insulin", "2007"], ["Metformin and clofibrate in maturity onset diabetes mellitus: advantages of combined treatment", "1979"], ["Mechanism of metformin action in obese and lean noninsulin\u2010dependent diabetic subjects", "1991"], ["Combined metformin/glyburide treatment in NIDDM patients not optimally responding to maximum dose sulfonyluria: Results of a multicenter trial.", "1993"], ["Comparison of glycaemic control and cardiovascular risk profile in patients with type 2 diabetes during treatment with either repaglinide or metformine", "2003"], ["Long\u2010term effect of glimepiride and rosiglitazone on non\u2010conventional cardiovascular risk factors in metformin\u2010treated patients affected by metabolic syndrome: a randomized, double\u2010blind clinical trial", "2005"], ["Metformin\u2010pioglitazone and metformin\u2010rosiglitazone effects on non\u2010conventional cardiovascular risk factors plasma levels in type 2 diabetic patients with metabolic syndrome", "2006"], ["Effects of nateglinide and glibenclamide on prothrombotic factors in naive type 2 diabetic patients treated with metformin: a 1\u2010year, double\u2010blind, randomized clinical trial", "2007"], ["Rosiglitazone Therapy Improves Insulin Resistance Parameters in Overweight and Obese Diabetic Patients Intolerant To Metformin", "2008"], ["Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study", "2009"], ["[Long range results (5 years) in the treatment of stable diabetes with low doses of clorpropamide\u2010metformin (author's transl)]", "1978"], ["Dimethyldiguanide in diabetes mellitus: Report of a small trial", "1960"], ["Metformin monotherapy for obese non\u2010insulin\u2010dependent diabetes. A double\u2010blind evaluation", "1988"], ["Continuing metformin when starting insulin in patients with type 2 diabetes: a double\u2010blind randomized placebo\u2010controlled trial", "2005"], ["Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes", "2007"], ["Piioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo\u2010controlled study", "2000"], ["The effects of oral hypoglycaemic drugs on serum lipids and lipoproteins in non\u2010insulin\u2010dependent diabetes (NIDDM)", "1991"], ["The effects of pioglitazone and metformin on plasma visfatin levels in patients with treatment naive type 2 diabetes mellitus", "2008"], ["Short\u2010term effects of metformin in type 2 diabetes", "2007"], ["Short\u2010term effects of metformin in type 2 diabetes", "2007"], ["A comparison of preconstituted, fixed combinations of low\u2010dose glyburide plus metformin versus high\u2010dose glyburide alone in the treatment of type 2 diabetic patients", "1999"], ["The effect of metformin treatment on VEGF and PAI\u20101 levels in obese type 2 diabetic patients", "2008"], ["Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: A randomized trial", "2008"], ["Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas", "1996"], ["Effects of metformin on fibrinogen levels in obese patients with type 2 diabetes", "1998"], ["Effect on glycemic control of the addition of 2.5 mg glipizide GITS to metformin in patients with T2DM", "2005"], ["Impaired beta\u2010cell responses improve when fasting blood glucose concentration is reduced in non\u2010insulin\u2010dependent diabetes", "1988"], ["Antihyperglycemic treatment in diabetics with coronary disease: Increased metformin\u2010associated mortality over a 5\u2010year follow\u2010up", "1999"], ["Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial", "2000"], ["Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects", "2008"], ["Intensive insulin therapy combined with metformin in obese type 2 diabetic patients", "2000"], ["Efficacy, dose\u2010response relationship and safety of once\u2010daily extended\u2010release metformin (Glucophage XR) in type 2 diabetic patients with inadequate glycaemic control despite prior treatment with diet and exercise: results from two double\u2010blind, placebo\u2010controlled studies", "2005"], ["[Gliclazide and metformin combination in patients with type 2 diabetes. Preliminary data]", "1998"], ["The metabolic effects of once daily extended\u2010release metformin in patients with type 2 diabetes: A multicentre study", "2008"], ["Efficacy and safety of exenatide in patients of Asian descent with type 2 diabetes inadequately controlled with metformin or metformin and a sulphonylurea", "2009"], ["Efficacy of metformin in type II diabetes: results of a double\u2010blind, placebo\u2010controlled, dose\u2010response trial", "1997"], ["Simultaenous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes", "2002"], ["Metformin\u2010glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy", "2006"], ["[Chlorpropamide\u2010metformin in obese diabetics or diabetics with side effects from sulfonylureas. 2\u2010year results]", "1971"], ["The dipeptidyl peptidase\u20104 inhibitor PHX1149 improves blood glucose control in patients with type 2 diabetes mellitus", "2008"], ["Preserve\u2010beta: Two\u2010year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin", "2005"], ["Metformin for obese, insulin\u2010treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors", "1993"], ["Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control", "2001"], ["Efficacy and safety of vildagliptin monotherapy during 2\u2010year treatment of drug\u2010naive patients with type 2 diabetes: Comparison with metformin", "2008"], ["Multicenter, randomized, double\u2010mased, parallel\u2010group assessment of simultaneous glipizide/metformin as second\u2010line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea", "2003"], ["Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase\u20104 inhibitor, and metformin on glycemic control in patients with type 2 diabetes.[erratum appears in Diabetes Care. 2008 Aug;31(8):1713]", "2007"], ["Efficacy and safety of glimepiride plus metformin in a single presentation, as combined therapy, in patients with type 2 diabetes mellitus and secondary failure to glibenclamide, as monotherapy", "2004"], ["Efficacy and tolerability of vildagliptin in patients with type 2 diabetes inadequately controlled with metformin monotherapy", "2009"], ["Metformin in treatment of Diabetes mellitus", "1962"], ["Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes", "2007"], ["Metformin causes a reduction in basal and post\u2010venous occlusion plasminogen activator inhibitor\u20101 in type 2 diabetic patients", "1991"], ["The effects of high\u2010 and medium\u2010dose metformin therapy on cardiovascular risk factors in patients with type II diabetes", "1996"], ["Metformin reduces circulating Factor VII concentrations in patients with Type II Diabetes mellitus", "1998"], ["[Body mass index, blood lactate and therapeutic effectiveness of metformin in type II diabetes mellitus]", "1989"], ["Low dose metformin in the treatment of type II non\u2010insulin\u2010dependent diabetes: clinical and metabolic evaluations", "1990"], ["Meformin, plasma glucose and free fatty acids in type II diabetic out\u2010patients: results of a clinical study", "1997"], ["Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non\u2010insulin\u2010dependent) diabetes mellitus", "1989"], ["Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy?", "1991"], ["Monitoring of metabolic control in patients with non\u2010insulin\u2010dependent diabetes mellitus on oral hypoglycaemic agents: value of evening blood glucose determination", "1997"], ["Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome", "2009"], ["The effect of metformin on insulin resistance and serum lipid profiles", "2000"], ["Comparison of fixed\u2010dose rosiglitazone/metformin combination therapy with sulphonylurea plus metformin in overweight individuals with type 2 diabetes inadequately controlled on metformin alone", "2008"], ["Oral antidiabetic combination therapy with sulphonylureas and metformin", "1991"], ["Exanatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial", "2005"], ["Dimethyldiguanide (Glucophage, LA 6023) in Diabetes mellitus", "1961"], ["Comparative efficacy of metformin and glibenclamide in patients with non\u2010insulin\u2010dependent diabetes mellitus", "1991"], ["Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles", "1991"], ["Antihyperglycaemic efficacy, response prediction and dose\u2010response relations of treatment with metformin and sulphonylurea, alone and in primary combination", "1994"], ["Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double\u2010blind controlled study [see comments]", "1994"], ["Double\u2010blind trial of metformin in the therapy of non\u2010ketotic diabetics", "1979"], ["Metformin added to insulin therapy in poorly controlled Type\u2010II Diabetes", "1999"], ["Efficacy of 24\u2010week monotherapy with acarbose, metformin, or placebo in dietary\u2010treated NIDDM patients: the Essen\u2010II Study", "1997"], ["Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non\u2010insulin dependent diabetes by glucose tolerance test criteria", "1991"], ["Sulphonylurea failure in Type 2 Diabetes: Treatment with a basal insulin supplement", "1987"], ["A double\u2010blind randomized study comparing the effects of continuing or not continuin rosiglitazone and metformin therapy when starting insulin therapy in people with type 2 diabetes", "2007"], ["Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes", "2000"], ["Efficacy and tolerability of initial combination therapy with nateglinide and metformin in treatment\u2010naive patients with thpe 2 diabetes", "2004"], ["Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes", "1989"], ["Both slow\u2010release and regular\u2010form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus", "2007"], ["The mushroom Agaricus blazei Murill in combination with metformin and glicazide improves insulin resistance in type 2 diabetes: a randomized double\u2010blinded, and placebo\u2010controlled clinical trial", "2007"], ["[Effect of insulin plus rosiglitazone or metformin on serum N\u2010terminal pro\u2010brain natriuretic peptide in type 2 diabetes mellitus: a randomized\u2010controlled study]. [Chinese]", "2008"], ["Mechanism by which metformin reduces glucose production in type 2 diabetes", "2000"], ["Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin", "2006"], ["Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy", "1998"], ["Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus [see comments]", "1998"], ["Combined oral therapy in Diabetes", "1962"], ["Mechanism of metformin action in non\u2010insulin\u2010dependent diabetes", "1987"], ["Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: A randomized controlled trial", "2009"], ["Effects of short\u2010term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo\u2010controlled trial", "2005"], ["Comination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomized elderly patients with type 2 diabetes mellitus", "2007"], ["Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM", "1994"], ["Acarbose treatment of sulfonylurea\u2010treated non\u2010insulin dependent diabetics. A double\u2010blind cross\u2010over comparison of an alpha\u2010glucosidase inhibitor with metformin", "1984"], ["The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients", "1993"], ["A retrospective chart review of uncontrolled use of metformin as an add\u2010on therapy in type 2 diabetes", "1998"], ["Long\u2010term efficacy of rosiglitazone as monotherapy or in combination with metformin", "2000"], ["Addition of rosiglitazone to metformin is effective in obese, insulin\u2010resistant patients with Type 2 Diabetes", "2000"], ["Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial", "2002"], ["Comparison of tolbutamide and metformin in elderly diabetic patients", "1990"], ["Acarbose for the treatment of type II diabetes: the results of a Canadian multi\u2010centre trial [published erratum appears in Diabetes Res Clin Pract 1995 Sep;29(3):215]", "1995"], ["The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus", "2005"], ["Nateglinide combination therapy with basal insulin and metformin in patients with Type 2 diabetes", "2009"], ["Comparative eficacy of glimepiride and/or metformin with insulin in type 2 diabetes", "2006"], ["Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus", "2008"], ["Glycemic durability of rosiglitazone, metformin or glyburide monotherapy", "2006"], ["Efficacy and safety of therapy with metformin plus pioglitazone in the treatment of patients with type 2 diabetes: A double\u2010blind, placebo\u2010controlled, clinical trial", "2009"], ["Starting insulin therapy in type 2 diabetes: twice\u2010daily biphasic insulin aspart 30 plus metformin versus once\u2010daily insulin glargine plus glimepiride", "2006"], ["Effects of metformin anad rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes", "2005"], ["Effects of pretreatment with low\u2010dose metformin on metabolic parameters and weight gain by pioglitazone in Japanese patients with type 2 diabetes", "2008"], ["Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus\u2010An effect probably mediated by direct platelet PPARgamma activation", "2008"], ["Metformin and Lipoprotein (a) levels", "1999"], ["Troglitazone but not metformin restores insulin\u2010stimulated phosphoinositide 3\u2010kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjects", "2002"], ["Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin\u201018 is an independent factor for the improvement of homeostasis model assessment\u2010beta in type 2 diabetes mellitus", "2007"], ["Troglitazone or metformin in combination with sulfonylureas for patients with type 2 diabetes?", "1999"], ["[Therapy of diabetes mellitus using metformin. Clinical study on 60 patients]", "1975"], ["Sulfonylurea\u2010metformin\u2010combination versus sulfonylurea\u2010insulin\u2010combination in secondary failures of sulfonylurea monotherapy. Results of a prospective randomized study in 50 patients", "1991"], ["Long\u2010term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus", "2009"], ["The effect of the ingestions of Ginkgo Biloba extract (EGb 761) on the pharmacokinetics of metformin in non\u2010diabetic and type 2 diabetic subjects \u2010 A double\u2010blind placebo\u2010controlled crossover study", "2006"], ["Metformin, but not pioglitazone, decreases postchallenge plasma ghrelin levels in type 2 diabetic patients: A possible role in weight stability?", "2008"], ["Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes", "2006"], ["Type 2 diabetes in the elderly: an assessment of metformin (metformin in the elderly)", "1990"], ["Placebo\u2010controlled trial of the effects of guar gum and metformin on fasting blood glucose and serum lipids in obese, type 2 diabetic patients", "1990"], ["Acarbose in NIDDM patients with poor control on conventional oral agents", "1998"], ["[Evaluation of the efficacy of metformin\u2010glibenclamide treatment in overweight non\u2010insulin dependent diabetics]", "1992"], ["Favorable effects of pioglitazone and metformin compared with glicazide on lipoprotein subgractions in overweight patients with early type 2 diabetes", "2004"], ["Ciclazindol: an oral agent with weight reducing properties and hypoglycaemic activity", "1983"], ["Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non\u2010insulin\u2010dependent diabetes", "1998"], ["Comparison of extended\u2010release metformin in combination with a sulfonylurea (Glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double\u2010blind, randomized, contgrolled, phase III study", "2007"], ["Effects of rosiglitazone on fasting plasma fibroblast growth factor\u201021 levels in patients with type 2 diabetes mellitus", "2009"], ["Effect of insulin\u2010metformin combination on hepatic statosis in patients with type 2 diabetes", "2007"], ["Sodium\u2010glucose cotransport inhibition with dapagliflozin in type 2 diabetes", "2009"], ["Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes", "1983"], ["Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol\u20103,4,5\u2010(PO4)3 in muscle of diabetic subjects", "2006"], ["Targeting hyperglycaemia with either metformin or repaglinide in non\u2010obese patients with type 2 diabetes: results from a randomized crossover trial", "2007"], ["Impact of metformin versus repaglinide on non\u2010glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non\u2010obese patients with type 2 diabetes", "2008"], ["Different effect of acute and chronic oral metformin administration on glucose and insulin response to bread and to pasta in non\u2010insulin dependent diabetic patients", "1996"], ["Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus", "1999"], ["Blood pressure and cardiac auonomic nervous system in obese type 2 diabetic patients: effect of metformin administration", "2004"], ["Metabolic effects of metformin addition to chronic glibenclamide treatment in type 2 diabetes [see comments]", "1994"], ["Metformin improves hemodynamic and rheological responses to L\u2010arginine in NIDDM patients", "1996"], ["Mathematical modeling shows exenatide improved beta\u2010cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea", "2006"], ["Improved glycemic control with metformin\u2010glibenclamide combined tabled therapy (Glucovance) in type 2 diabetic patients inadequately controlled on metformin", "2002"], ["Effect of homocysteine\u2010lowering therapy on arterial elasticity and metabolic parameters in metformin\u2010treated diabetic patients", "2008"], ["Improved endothelial function with metformin in type 2 diabetes mellitus", "2001"], ["Long\u2010term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study", "2005"], ["A comparison of treatment with metformin and gliclazide in patients with non\u2010insulin\u2010dependent diabetes", "1988"], ["Effects of improved glycaemic control on calcium and magnesium homeostasis in type II diabetes", "1988"], ["Metformin increases insulin sensitivity and basal glucose clearance in type 2 (non\u2010insulin dependent) diabetes mellitus", "1991"], ["Utility of Metformin as a non\u2010hormonal agent in the treatment of Diabetes mellitus", "1963"], ["Metformin efficacy and tolerance in obese non\u2010insulin dependent diabetics: a comparison of two dosage schedules", "1989"], ["Evaluation of efficacy and safety of fixed dose combination of glimepiride 2 mg plus pioglitazone 15 mg plus metformin SR 500 mg in the management of patients with type\u20102 diabetes mellitus", "2005"], ["Repaglinide in combination therapy with metformin in Type 2 diabetes", "1999"], ["Effects of metformin on the glycemic control, lipid profile, and arterial blood pressure of type 2 diabetic patients with metabolic syndrome already on insulin", "2006"], ["The effect of metformin on glycemic control, serum lipids and lipoproteins in diet alone and sulfonylurea\u2010treated type 2 diabtic patients with sub\u2010optimal metabolic control", "2000"], ["[Treatment of obese diabetic patients using glucophage retard]", "1975"], ["Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with non\u2010insulin\u2010dependent (type 2) diabetes mellitus", "1996"], ["The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease", "2009"], ["Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes", "2004"], ["Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity\u2010onset diabetics", "1977"], ["Efficacy and safety of the dipeptidyl peptidase\u20104 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double\u2010blind, non\u2010inferiority trial", "2007"], ["Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes", "2009"], ["Treatment with the human once\u2010weekly glucagon\u2010like peptide\u20101 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone: A double\u2010blind placebo\u2010controlled study", "2009"], ["Efficacy and safety of adding the dipeptidyl peptidase\u20104 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A multicentre, randomised, double\u2010blind, placebo\u2010controlled study", "2009"], ["Comparison of bedtime NPH insulin or metformin combined with glibenclamide in secondary sulphonylurea failure in obese type II (NIDDM) patients", "1998"], ["Effect of metformin on insulin\u2010stimulated glucose turnover and insulin binding to receptors in Type 2 diabetes", "1987"], ["Comparative three\u2010month study of the efficacies of metformin and gliclazide in the treatment of NIDD", "1991"], ["Effect of metformin on serum lipoprotein lipase mass levels and LDL particle size in type 2 diabetes mellitus patients", "2007"], ["The influence of Dimethylbiguanide on Phenprocoumon elimination and its mode of action", "1983"], ["The effects of metformin and diet on plasma testosterone and leptin levels in obese men", "2001"], ["A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients", "2007"], ["Induction of long\u2010term glycemic control in type 2 diabetic patients using pioglitazone and metformin combination", "2007"], ["Pioglitazone vs glimepiride: Differential effects on vascular endothelial function in patients with type 2 diabetes", "2009"], ["Effect of pioglitazone compared with metformin on glycemic control and indicators of insulin sensitivity in recently diagnosed patients with type 2 diabetes", "2003"], ["The difficult choice of treatment for poorly controlled maturity onset diabetes: tablets or insulin?", "1984"], ["Platelet behaviour in non\u2010insulin\u2010dependent Diabetes \u2010 Influence of vascular complications, treatment and metabolic control", "1986"], ["The effect of Metformin on weight loss in obesity", "1965"], ["The effects of metformin on adipocyte insulin action and metabolic control in obese subjects with type 2 diabetes", "1989"], ["Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humans", "2009"], ["[A new oral antidiabetic medicine: N.N. Dimethylbiguanide. Clinical trial alternating a placebo with a sulfamide]", "1961"], ["Pioglitazone reduces monocyte activation in type 2 diabetes", "2009"], ["Combined metformin and insulin therapy for patients with type 2 diabetes mellitus [In Process Citation]", "2000"], ["Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: The LANCET randomized trial", "2009"], ["Effect of metformin on peripheral insulin sensitivity in non insulin dependent diabetes mellitus", "1986"], ["[Experience with the biguanide Glucophage]", "1964"], ["Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications", "2002"], ["The effect of glibenclamide and metformin on serum lipoproteins in type 2 diabetes", "1988"], ["The reduction of low density lipoprotein cholesterol by metformin is maintained with long\u2010term therapy", "1989"], ["Therapeutic effect of glibenclamide in a fixed combination with metformin or phenformin in NIDDM patients", "1996"], ["Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts)", "2009"], ["Twice\u2010daily dosing of a repaglinide/metformin fixed\u2010dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet", "2009"], ["Long\u2010term effects of exenatide therapy over 82 weeks on glycaemic control and weight in over\u2010weight metformin\u2010treated patients with type 2 diabetes mellitus", "2006"], ["Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes", "2008"], ["Combined metformin\u2010sulfonylurea treatment of patients with noninsulin\u2010dependent diabetes in fair to poor glycemic control", "1992"], ["Adding metformin versus insulin dose increase in insulin\u2010treated but poorly controlled Type 2 diabetes mellitus: an open\u2010label randomized trial", "1998"], ["[Chlorpropamide\u2010dimethylbiguanide combination in the control of diabetes mellitus with complications]", "1969"], ["Glucose and lipid metabolism in non\u2010insulin\u2010dependent diabetes, effect of metformin", "1991"], ["Nateglinide or gliclazide in combination with metformin for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone: 1\u2010year trial results", "2007"], ["Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30\u2010week, randomized, double\u2010blind, placebo\u2010controlled, parallel\u2010group study", "2005"], ["The effects of metformin on glycemic control and serum lipids in insulin\u2010treated NIDDM patients with suboptimal metabolic control [see comments]", "1998"], ["Long\u2010term effects of pioglitazone and metformin on insulin sensitivity in patients with type 2 diabetes mellitus", "2005"], ["Free fatty acid kinetics during long\u2010term treatment with pioglitazone added to sulfonylurea or metformin in Type 2 diabetes", "2009"], ["Clinical experience with acarbose: results of a Canadian multicentre study", "1995"], ["Six\u2010month effectiveness and tolerability of pioglitazone in combination with sulfonylureas or metformin for the treatment of type 2 diabetes mellitus", "2008"], ["Addition of benflouorex to biguanide improves glycemic control in obese non\u2010insulin\u2010dependent diabets: a double\u2010blind study versus placebo", "1999"], ["Rosiglitazone plus metformin is effective and well tolerated in clinical practice: results from large observational studies in people with type 2 diabetes", "2005"], ["Efficacy and safety of Acarbose in Metformin\u2010treated patients with Type 2 Diabetes", "1998"], ["Triple therapy in type 2 diabetes: Insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin\u2010naive patients", "2006"], ["Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD\u20105 met+SU): A randomised controlled trial", "2009"], ["Effects of metformin or rosiglitazone on serum concentrations of homocysteine, flotae and vitamin B12 in patients with type 2 diabetes mellitus", "2007"], ["[The combination of insulin and metformin in obese patients with type\u20102 diabetes mellitus]", "1999"], ["Changes in insulin receptor tyrosine kinase activity associated with metformin treatment of type 2 diabetes", "1995"], ["Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double\u2010blind, randomized trial", "2004"], ["Efficacy and treatment satisfaction of once\u2010daily insulin glargine plus one or two oral antidiabetic agents versus continuing premixed human insulin in patients with type 2 diabetes previously on long\u2010term conventional insulin therapy: The SWITCH pilot study", "2008"], ["Metformin\u2010induced changes in serum lipids, lipoproteins, and apoproteins in non\u2010insulin\u2010dependent diabetes mellitus", "1990"], ["[Long\u2010term (3 year) results of the treatment of stable diabetes with low doses of chlopropamide\u2010metformin]", "1973"], ["Efficacy, tolerability and safety of a novel once\u2010daily extended\u2010release metformin in patients with type 2 diabetes", "2006"], ["Comparison between vildagliptin and metformin to sustain reductions in HbA(1c) over 1 year in drug\u2010naive patients with Type 2 diabetes", "2007"], ["Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: A 24\u2010week, double\u2010blind, randomized trial", "2009"], ["Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes", "2008"], ["Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus", "2006"], ["Comparison of effect of metformin in combination with glimepiride and glibenclamide on glycaemic control in patient with type 2 Diabetes Mellitus", "2009"], ["[Assessment of efficacy and safety of acarbose in the treatment of diabetes mellitus. Observation study in the conditions of general health care]", "1999"], ["Effect of metformin on glycaemic control in type 2 diabetes in daily practice: a retrospective study", "2000"], ["Metabolic control in diabetic subjects in three Swedish areas with high, medium and low sales of antidiabetic drugs", "1991"], ["Improved glycaemic control with miglitol in inadequately\u2010controlled type 2 diabetics", "2001"], ["[Report on five years experience with Metformin]", "1963"], ["Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well\u2010controlled type 2 diabetes", "2006"], ["A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinial atherosclerosis in patients with type 2 diabetes", "2007"], ["[Experience with Dimethylbiguanide in late failrues of oral diabetes therapy]", "1965"], ["Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetes", "2002"], ["Metabolic effects of metformin in non\u2010insulin\u2010dependent diabetes mellitus", "1995"], ["Comparative effects of glibenclamide and metformin on ambulatory blood pressure and cardiovascular reactivity in NIDDM", "1997"], ["Safety and efficacy of metformin in a restricted formulary", "1999"], ["Combined trial of Acetohexamide and two Diguanide preparations", "1964"], ["A prospective study of the effect of 12 months treatment on serum lipids and apolipoproteins A\u2010I and B in Type 2 (non\u2010insulin\u2010dependent) diabetes", "1982"], ["Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus", "2007"], ["Effects of metformin treatment on whole\u2010body and splanchnic amino acid turnover in mild type 2 diabetes", "1994"], ["Effects of gliclazide versus metformin on the clinical profile and lipid peroxidation markers in type 2 diabetes", "1999"], ["Relationship between plasminogen activator inhibitor type\u20101 plasma levels and the lipoprotein(a) concentrations in non\u2010insulin\u2010dependent diabetes mellitus", "1996"], ["Prospective randomized two\u2010years clinical study comparing additional metformin treatment with reducing diet in type 2 diabetes", "1991"], ["Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and fene expression in adipose tissue in patients with type 2 diabetes", "2004"], ["Efficacy and safety of topiramite in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double\u2010blind, placebo\u2010controlled study", "2007"], ["Combination treatment with metformin and glibenclamide versus single\u2010drug therapies in type 2 diabetes mellitus: a randomized, double\u2010blind, comparative study", "2003"], ["Comparison of glargine insulin versus rosiglitazone addition in poorly controlled trype 2 diabetic patients on metformin plus sulfonylurea", "2006"], ["Comparison of combined therapies in treatment of secondary failure to glyburide", "1992"], ["Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas. Is it predictable?", "1998"], ["Effects of rosiglitazone on plasma brain natriuretic peptide levels and myocardial performance index in patients with type 2 diabetes mellitus", "2007"], ["Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension", "2001"], ["A randomized double\u2010blind trial of Acarbose in Type II Diabetes shows improved glycemic control over 3 years (UK Prospective Diabetes Study 44)", "1999"], ["Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial", "2006"], ["Recognition of fasting or overall hyperglycaemia when starting insulin treatment in patients with type 2 diabetes in general practice", "2007"], ["Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high\u2010energy phosphate metabolism in patients with well\u2010controlled type 2 diabetes mellitus.[see comment]", "2009"], ["Meglitol combined with metformin improves glycaemic control in type 2 diabetes", "2001"], ["Effects of alpha\u2010glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non\u2010insulin\u2010dependent diabetes mellitus", "1995"], ["Biphastic insulin aspart 30: Better glycemic control than with premixed human insulin 30 in obese patients with Type 2 diabetes", "2009"], ["[Median\u2010term (4 months) treatment with glibenclamide + metformin substituting for glibenclamide + fenformin lowers the lacticemia levels in type\u20102 diabetics (NIDDM)]", "1992"], ["Treatment of NIDDM patients with secondary failure to glyburide: comparison of the addition of either metformin or bed\u2010time NPH insulin to glyburide", "1991"], ["Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: a double\u2010blind, randomized study with metformin", "2005"], ["[The effect of metformin on fasting and postprandial insulin secretion in obese patients with diabetes mellitus type 2]. [Serbian]", "2007"], ["Effects of rosiglitazone added to submaximal doses of metformin compared with dose escalation of metformin in type 2 diabetes: the EMPIRE study", "2005"], ["The effects of dexfenluramine on blood glucose control in patients with Type 2 Diabetes", "1992"], ["Obese patients with type 2 Diabetes poorly controlled by insulin and metformin: Effects of adjunctive Dexfenfluramine therapy on glycaemic control", "1994"], ["Comparison of acarbose and metformin in patients with Type 2 diabetes mellitus insufficiently controlled with diet and sulphonylureas: a randomized, placebo\u2010controlled study", "1999"], ["A comparison of metformin versus guar in combination with sulphonylureas in the treatment of non insulin dependent diabetes", "1989"], ["One\u2010year Acarbose treatment raises fasting serum acetate in Diabetic patients", "1995"], ["Miglitol, an alpha\u2010glucosidase inhibitor, prevents the metformin\u2010induced fall in serum folate and vitamin B12 in subjects with type 2 diabetes", "2000"], ["Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients", "1990"], ["Metformin and insulin therapy decreases glycosylated hemoglobin and insulin requirement in Type 2 Diabetes", "2000"], ["Combination of insulin and metformin in the treatment of type 2 diabetes", "2002"], ["Effects of short\u2010term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo\u2010controlled trial", "2003"], ["Does metformin decrease blood pressure in patients with type 2 diabetes intensively treated with insulin?", "2005"], ["The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin: a multicenter, randomized, double\u2010blind, placebo\u2010controlled trrial", "2001"], ["Comparison of metabolic effects of pioglitazone, metformin, and glimepiride over 1 year in Japanese patients with newly diagnosed type 2 diabetes", "2005"], ["Serum transforming growth factor\u2010beta 1 levels in normoalbuminuric and normotensive patients with type 2 diabetes. Effect of metformin and rosiglitazone", "2008"], ["Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial [see comments]", "1999"], ["A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin\u2010treated type 2 diabetic patients", "1999"], ["Efficacy and safety of the human glucagon\u2010like peptide\u20101 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD\u20104 Met+TZD)", "2009"]]}